Jeremy is an oncological surgeon with primary interest in bladder cancer. Previously, he conducted a randomised trial comparing between bipolar and monopolar transurethral resection of bladder tumour (TURBT) and showed that bipolar TURBT was able to achieve a higher detrusor sampling rate than monopolar TURBT. He has also developed a global consensus statement on en bloc resection of bladder tumour (ERBT). A total of 99 statements reached consensus and they have become the standard reference for urologists practising en bloc resection globally. Recently, he published the results of the EB-StaR study, which is a multi-centre randomised trial demonstrating that ERBT could reduce the 1-year recurrence rate from 38.1% to 28.5% for patients with ≤3cm non-muscle-invasive bladder cancer (NMIBC). He is also leading a phase 2 clinical trial on modified en bloc resection for large bladder tumours (>3cm). He is currently serving as a panel member of the European Association of Urology (EAU) Guidelines on NMIBC and Upper Tract Urothelial Carcinoma, and he is dedicated to high-quality research work in this area.
Jeremy has received numerous research grants with a total funding of more than 10 million USD. He has published more than 400 articles in peer-reviewed journals such as European Urology, European Urology Oncology, European Urology Focus and Nature Reviews Urology. He was the Chairperson of the Younger Fellows Chapter of the College of Surgeons of Hong Kong (2019-2021), the Chair of the Young Fellows Chapter of the Hong Kong Academy of Medicine (2021-2022), and he has been the Director of the Lions Kidney Educational Centre & Research Foundation since 2017. He is also the founder of the UroSoMe (Urology Social Media) working group and he believes that social media plays an important role in the modern era of medicine.
14th August 2025
Time |
Session |
|
08:00
16:50
|
-
Part I: Urolithiasis & Technology (Fundamental)
-
Opening Remarks & Congratulatory Remarks from Experts
-
Welcome ETS
-
Session: Reshaping Upper Tract Endourology Intervention
-
How Suction Changed My Hospital Practice of Flexible Ureteroscopy
-
Digitalization in Suction PCNL Can Change Practice
-
Endoscopic Combined Intra Renal Surgery: New Frontiers
-
Navigating the Complex Renal Anatomy with FANS?
-
Suction PCNL vs Suction RIRS? Do We Have a Winner
-
Q&A
-
Session: Global Leaders Share the Evidence
-
Thullium Fibre Laser: A Unique Laser for Urological Use
-
Do We Need Augmented Reality for Renal Stone Management?
-
Battle of the Robots in Flexible Ureteroscopy: What's the Verdict?
-
Transurethral En Bloc Resection of Bladder Tumor: Where Are We Now?
-
Best Laser for UTUC
-
Q&A
-
Session: Surgical Advancement of Asia for Stone Management: ECIRS
-
Impact of Ureteral Access Sheath on Kidney Stones before and after FANS
-
How to Perform Supine PCNL in Pediatrics? Is It Different from Adults?
-
ESWL for Ureteric Stones: Art of Achieving 100% Stone Free Rate
-
Discussion
-
Part II: Endoluminal Technology Symposium (ETS), Advance Course of Urolithiasis & Technology, Company Sponsored Symposium
-
1st Company Session: Luncheon Symposium
-
Single-Use Cysto-Nephro Scope in ECIRS/ PCNL
-
Experimental and Real World Take Away Messages on DISS
-
Q & A
-
2nd Company Session
-
The Power of Magneto and Vapour Tunnel in Holep
-
Take Home Messages to Prevent Bladder Neck Contracture in Enucleation
-
Q & A
-
3rd Company Session
-
Intra Renal Pressure Defines Outcomes: Current Evidence
-
Pressure Management Strategy in RIRS using Tidor System
-
Q & A
-
4th Company Session
-
The Power of Powerbend in Management of Lower Pole and Complex Stones.
-
What I Need as a Clinician in Single Use Scopes
-
Q & A
-
5th Company Session
-
Clearpetra the Sheath of Choice for Lower Pole Stones
-
How to Use Clearpetra Shetah to Minimize Post Operative Stenting after FANS
-
Q & A
TICC - 2F 201DE
|
08:30
17:00
|
-
Opening Remarks
-
ARUS–PRUS Partnership Ceremony: A New Chapter in Asia Robotic Urology Collaboration
-
Session 1: Advances in Robotic Surgery
-
-
From Console to Cloud: The Evolution of Robotic Telesurgery in Urology – Innovations, Trials, and Ethical Frontiers
-
Open Surgery Training: Is It Necessary in the Era of Robotics?
-
Hinotori Robotic System in Urological Surgery: Clinical Applications and Future Potential
-
What's Next in Urologic Robotics in Asia: Future Perspectives
-
Panel Discussion
-
Coffee Break
-
Session 2: Robotic Prostate Surgery
-
Lessons from 20,000 Robotic Prostatectomies: A Global Expert’s Perspective
-
Aquablation Revolutionizing BPH Treatment: A New Era of Minimally Invasive Therapy-Tungs' Taichung Metroharbor Hospital Experience
-
Debulking the Primary: Robotic Cytoreductive Radical Prostatectomy
-
Robotic Radical Prostatectomy: Trying to Fit the Right Surgery to the Right Patient
-
Single-Port vs. Multi-Port Robotic Prostatectomy: Balancing Innovation, Precision, and Outcomes
-
Comparison of Hood technique vs Retzius sparing RARP: Beijing Hospital Experience.
-
Panel Discussion
-
Lunch Break
-
Session 3: Robotic Kidney and Vascular Surgery
-
Expanding horizons: SP for complex RAPN
-
Partial Nephrectomy: Managing Complications and Challenging Cases
-
Robotic IVC Thrombectomy: Expanding the Role of Robotics in Vascular Involvement
-
Panel Discussion
-
Session 4: Robotic Reconstructive Surgery
-
Robotic Sacrocolpopexy: Techniques, Challenges, and Long-Term Outcomes
-
Robotic Vesico-Rectal and Vesico-Vaginal Repair: Innovations in Complex Fistula Management
-
Robotic Ureteral Reconstruction: Managing Strictures and Injuries
-
Panel Discussion
-
Coffee Break
-
Session 5: Robotic Bladder Surgery
-
Mastering the Details: Tips and Tricks on Robotic Radical Cystectomy
-
Step-by-Step: Intra-Corporeal Orthotopic Bladder Creation
-
Robotic Pelvic LN Dissection: A critical Component of Bladder Cancer Surgery
-
Panel Discussion
-
Honoring the Past, Embracing the Future: ARUS Business Session and Presidential Handover
-
ARUS Closing Remarks
TICC - 1F 101D
|
09:00
15:00
|
-
Welcome Remarks
-
Welcome Remarks
-
Bladder Cancer Track
-
MDT Discussion: Treating High-Risk BCG Refractory NMIBC in a ECOG2 75-year-old
-
Debate: Bladder Preservation Should Be Considered for All Cases of MIBC
-
Technical Pearls: Node Dissection in Robotic Cystectomy
-
Technical Pearls: Robotic Intra-Corporeal OBS
-
Practice Changing Papers
-
Coffee Break
-
Prostate Cancer Track
-
MDT Discussion: Personalizing Treatment in High Volume CSPC
-
Debate: PIRADS 4/5 Negative Biopsies Should
-
Technical Pearls: Retzius Sparing
-
Technical Pearls: Nerve-Sparing
-
Technical Pearls: Total Extraperitoneal Technique
-
Practice Changing Papers
-
Group Photo
-
Lunch Break
-
Kidney Cancer Track
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is Minimally Invasive Treatment Feasible?
-
Treating SRM in a 65-Year-Old ECOG 1 with Multiple Previous Operations-Is SBRT the New Kid on the Block?
-
Debate: Should We Only Offer Consolidative Cytoreductive Nephrectomy in Metastatic RCC?
-
Technical Pearls: Wheel-Barrow Techniques
-
Technical Pearls: Renorrhaphy Techniques
-
Practice Changing Papers
-
Closing Remarks
TICC - 1F 101A
|
15th August 2025
Time |
Session |
|
13:30
15:00
|
Effective Communication Conflict Resolution; Develop a Compelling Vision to Motivate Others
-
Effective Communication Conflict Resolution; Develop a Compelling Vision to Motivate Others
-
Welcome Remarks
-
Introduction to Young Leadership 2025
-
Introduction to Asia School of Urology
-
To Publish or not to Publish?
-
Bringing Innovation to Patient
-
-
How to Escape Surgical Complications
TICC - 3F Banquet Hall
|
16th August 2025
Time |
Session |
|
12:00
13:00
|
Navigating Urological Oncology: Best Approaches for Advanced Prostate and Bladder Cancer in Today's Era
-
Welcome
-
The Role of Degarelix in the Era of ARPI
-
Case Presentation on a Locally Advanced PCa Patient with CV Risks
-
Novel Intravesical Therapeutics in the Evolving Landscape of NMIBC
-
Panel Discussion
-
Closing
TICC - 1F 101B
|
13:30
15:00
|
|
17th August 2025
Time |
Session |
|
08:30
10:00
|
-
Impact of Relugolix versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study (European Urology, 2023)
-
SIU Lecture: Role of MISTs in Male LUTS Surgical Management (Will TUR-P/ Laser Prostatectomy be Replaced?)
-
Updates on Molecular Classification and Diagnostics of Upper Urinary Tract Urothelial Carcinoma
-
A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-Grade Urothelial Carcinoma from Digitized Urine Cytology
-
Recommendations in Laser Use for the Treatment of Upper Tract Urothelial Carcinoma
-
UTUC Treatment — Evidence & Guideline Recommendation
TICC - 3F Banquet Hall
|